NCT04212767

Brief Summary

The present study aimed to evaluate the clinical effect of platelet-rich fibrin to improve epithelialization and decrease postoperative pain in post extraction sockets

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 17, 2019

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 30, 2019

Completed
Last Updated

December 30, 2019

Status Verified

December 1, 2019

Enrollment Period

2.3 years

First QC Date

December 17, 2019

Last Update Submit

December 24, 2019

Conditions

Keywords

Tooth extractionPlatelet-rich fibrinSoft tissue

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the soft tissue epithelialization speed in post-extraction sockets

    One and two weeks after extraction, an assessment of soft tissue healing around the sockets was performed using the healing index system described by Landry et al. The following parameters were used to assess the level of healing: colour of tissues; epithelialisation of wound margins; presence of bleeding on palpation; granulation; and suppuration. The level of healing was scored as very poor, poor, good, very good, or excellent.

    90 days

Secondary Outcomes (2)

  • Postoperative pain

    90 days

  • Number of consumed analgesic

    90 days

Study Arms (2)

Test group

EXPERIMENTAL

Post-extraction sockets covered with Platelet-Rich Fibrin membrane (n=16)

Procedure: Alveolar socket preservation with Platelet-rich fibrin

Control Goroup

NO INTERVENTION

Post-extraction sockets left to spontaneous healing/clot and primary closure (n=16).

Interventions

The sockets of the test group will be filled with two platelet-rich fibrin membranes followed by suture

Also known as: Platelet-Rich Fibrin
Test group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants ≥ 18 years of age;
  • Participants needing molar extraction in the mandible or maxilla region.

You may not qualify if:

  • Smokers;
  • Pregnant;
  • Participants with motor difficulties that impeded or hampered hygien;
  • Participants with decompensated metabolic diseases;
  • Participants with periodontal disease;
  • Participants with history of radiotherapy or use of bisphosphonates.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dental Clinical Research Center of the Fluminense Federal University

Niterói, Rio de Janeiro, 24020-140, Brazil

Location

Related Publications (3)

  • Lei L, Yu Y, Han J, Shi D, Sun W, Zhang D, Chen L. Quantification of growth factors in advanced platelet-rich fibrin and concentrated growth factors and their clinical efficacy as adjunctive to the GTR procedure in periodontal intrabony defects. J Periodontol. 2020 Apr;91(4):462-472. doi: 10.1002/JPER.19-0290. Epub 2019 Nov 17.

    PMID: 31471902BACKGROUND
  • Castro AB, Cortellini S, Temmerman A, Li X, Pinto N, Teughels W, Quirynen M. Characterization of the Leukocyte- and Platelet-Rich Fibrin Block: Release of Growth Factors, Cellular Content, and Structure. Int J Oral Maxillofac Implants. 2019 July/August;34(4):855-864. doi: 10.11607/jomi.7275. Epub 2019 Feb 11.

    PMID: 30742137BACKGROUND
  • Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e45-50. doi: 10.1016/j.tripleo.2005.07.009. Epub 2006 Jan 10.

MeSH Terms

Conditions

Stomatognathic Diseases

Study Officials

  • Vittorio Moraschini, PhD

    Fluminense Federal University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, parallel-arm, randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 17, 2019

First Posted

December 30, 2019

Study Start

April 15, 2017

Primary Completion

August 15, 2019

Study Completion

November 15, 2019

Last Updated

December 30, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations